Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.

Rosendaal FR, Vessey M, Rumley A, Daly E, Woodward M, Helmerhorst FM, Lowe GD.

Br J Haematol. 2002 Mar;116(4):851-4.

PMID:
11886391
2.

Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.

Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group.

Circulation. 2005 Nov 29;112(22):3495-500. Epub 2005 Nov 21.

3.

The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.

Douketis JD, Julian JA, Crowther MA, Kearon C, Bates SM, Barone M, Piovella F, Middeldorp S, Prandoni P, Johnston M, Costantini L, Ginsberg JS.

Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E106-13. doi: 10.1177/1076029610387587. Epub 2010 Dec 15.

PMID:
21159708
4.

Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.

Herrington DM, Vittinghoff E, Howard TD, Major DA, Owen J, Reboussin DM, Bowden D, Bittner V, Simon JA, Grady D, Hulley SB.

Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):1012-7.

5.

Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.

Smith NL, Heckbert SR, Lemaitre RN, Reiner AP, Lumley T, Rosendaal FR, Psaty BM.

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2807-12. Epub 2006 Sep 14.

6.

Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.

Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ.

Br J Haematol. 2007 Oct;139(2):289-96.

PMID:
17897305
7.
8.

Old and new risk factors for upper extremity deep venous thrombosis.

Blom JW, Doggen CJ, Osanto S, Rosendaal FR.

J Thromb Haemost. 2005 Nov;3(11):2471-8.

9.

Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction.

Tanis BC, Bloemenkamp DG, van den Bosch MA, Kemmeren JM, Algra A, van de Graaf Y, Rosendaal FR.

Br J Haematol. 2003 Aug;122(3):471-8.

PMID:
12877676
10.

Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.

Lowe G, Woodward M, Vessey M, Rumley A, Gough P, Daly E.

Thromb Haemost. 2000 Apr;83(4):530-5.

PMID:
10780311
11.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

12.

Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.

Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).

Thromb Haemost. 2008 Jan;99(1):223-8. doi: 10.1160/TH07-08-0515.

PMID:
18217158
13.
14.

Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A)

Longstreth WT Jr, Rosendaal FR, Siscovick DS, Vos HL, Schwartz SM, Psaty BM, Raghunathan TE, Koepsell TD, Reitsma PH.

Stroke. 1998 Mar;29(3):577-80.

15.

Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.

Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr, Raghunathan TE, Koepsell TD, Reitsma PH.

Blood. 1997 Apr 15;89(8):2817-21.

16.
17.

D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.

Andreescu AC, Cushman M, Rosendaal FR.

Thromb Haemost. 2002 Jan;87(1):47-51.

PMID:
11858188
18.

Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.

Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J.

Thromb Haemost. 2002 Jul;88(1):5-11.

PMID:
12152677
19.

Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.

Psaty BM, Smith NL, Lemaitre RN, Vos HL, Heckbert SR, LaCroix AZ, Rosendaal FR.

JAMA. 2001 Feb 21;285(7):906-13.

PMID:
11180734
20.

Minor events and the risk of deep venous thrombosis.

Eekhoff EM, Rosendaal FR, Vandenbroucke JP.

Thromb Haemost. 2000 Mar;83(3):408-11.

PMID:
10744145
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk